NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+87.13%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.49B
AUM Growth
+$2.49B
Cap. Flow
-$375M
Cap. Flow %
-15.07%
Top 10 Hldgs %
64.37%
Holding
51
New
1
Increased
2
Reduced
3
Closed
5

Top Buys

1
AKUS
Akouos, Inc. Common Stock
AKUS
$96.7M
2
TRVI icon
Trevi Therapeutics
TRVI
$9.87M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
$7.36M

Top Sells

1
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
$295M
2
MRSN icon
Mersana Therapeutics
MRSN
$93.7M
3
EPZM
Epizyme, Inc
EPZM
$67.9M
4
ARDX icon
Ardelyx
ARDX
$17.3M
5
SURF
Surface Oncology, Inc. Common Stock
SURF
$6.2M

Sector Composition

1 Healthcare 79.03%
2 Technology 16.28%
3 Consumer Discretionary 2.25%
4 Industrials 0.58%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SPT icon
1
Sprout Social
SPT
$929M
$244M 9.82% 9,046,080 – –
MRSN icon
2
Mersana Therapeutics
MRSN
$36.5M
$186M 7.49% 7,959,520 -4,004,129 -33% -$93.7M
OYST
3
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$171M 6.88% 5,925,287 – –
ADAP
4
Adaptimmune Therapeutics
ADAP
$15.6M
$171M 6.87% 17,082,611 – –
ALLK
5
DELISTED
Allakos
ALLK
$163M 6.55% 2,268,188 – –
CRSP icon
6
CRISPR Therapeutics
CRSP
$4.71B
$154M 6.18% 2,090,678 – –
NET icon
7
Cloudflare
NET
$72.7B
$146M 5.87% 4,059,376 – –
BDTX icon
8
Black Diamond Therapeutics
BDTX
$157M
$145M 5.85% 3,449,845 – –
ELVN icon
9
Enliven Therapeutics
ELVN
$1.2B
$111M 4.46% 4,017,170 – –
RYTM icon
10
Rhythm Pharmaceuticals
RYTM
$6.85B
$110M 4.4% 4,912,306 – –
AKUS
11
DELISTED
Akouos, Inc. Common Stock
AKUS
$96.7M 3.89% +4,298,488 New +$96.7M
ARDX icon
12
Ardelyx
ARDX
$1.53B
$94.3M 3.79% 13,633,582 -2,501,465 -16% -$17.3M
AUPH icon
13
Aurinia Pharmaceuticals
AUPH
$1.58B
$84.1M 3.38% 5,172,683 – –
MIRM icon
14
Mirum Pharmaceuticals
MIRM
$3.71B
$81.5M 3.28% 4,187,801 – –
CSPR
15
DELISTED
Casper Sleep Inc.
CSPR
$55.8M 2.25% 6,226,040 – –
TRIL
16
DELISTED
Trillium Therapeutics Inc.
TRIL
$46.4M 1.87% 5,736,363 – –
TRVI icon
17
Trevi Therapeutics
TRVI
$883M
$39.1M 1.57% 5,940,796 +1,499,436 +34% +$9.87M
MEIP icon
18
MEI Pharma
MEIP
$160M
$35.2M 1.42% 8,533,072 – –
CBIO
19
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$34.2M 1.37% 9,089,041 – –
GRTX
20
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$31.2M 1.25% 4,362,986 – –
PHAS
21
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$30.6M 1.23% 6,643,704 – –
AFMD
22
DELISTED
Affimed
AFMD
$28.3M 1.14% 6,126,488 – –
OBSV
23
DELISTED
ObsEva SA Ordinary Shares
OBSV
$27M 1.09% 4,586,563 – –
LQDA icon
24
Liquidia Corp
LQDA
$2.38B
$20.9M 0.84% 2,486,062 – –
AVEO
25
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$20.4M 0.82% 3,952,958 +1,428,571 +57% +$7.36M
1
2 3